Amide-substituted pyridinyltriazole derivatives and uses thereof

US11091463B2 · kind B2 · utility

Assignee

• Bayer Pharma Aktiengesellschaft · DE

Inventors

• Marie-Pierre Collin · Wuppertal, DE
• Peter Kolkhof · Wuppertal, DE
• Thomas Neubauer · Wuppertal, DE
• Chantal Fuerstner · Neheim, DE
• Elisabeth Pook · Wuppertal, DE
• Matthias Beat WITTWER · Riehen, CH
• Klemens Lustig · Wuppertal, DE
• Anja BUCHMUELLER · Essen, DE
• Hanna Tinel · Wuppertal, DE
• Karoline Droebner · Velbert, DE
• Thomas MONDRITZKI · Essen, DE
• Heiko Schirmer · Solingen, DE
• Axel Kretschmer · Wuppertal, DE
• Carsten Schmeck · Wuppertal, DE
• Pierre Wasnaire · Mülheim an der Ruhr, DE
• Hana Cernecka · Wuppertal, DE

Key dates

• Filing date: Sep 23, 2019
• Grant date: Aug 17, 2021
• Expiry date: Sep 23, 2039

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P13/12
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention relates to novel 5-(carboxamide)-1-pyridinyl-1,2,4-triazole derivatives, to processes for the preparation of such compounds, to pharmaceutical compositions containing such compounds, and to the use of such compounds or compositions for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of renal and cardiovascular diseases.